Damage to the blood-brain barrier during experimental cerebral malaria results from synergistic effects of CD8+ T cells with different specificities

Infection and Immunity

Volumn 82, Issue 11, 2014, Pages 4854-4864

  Poh, Chek Meng ^a,b   Howland, Shanshan W ^a   Grotenbreg, Gijsbert M ^b,c   Rénia, Laurent ^a  

^a AGENCY FOR SCIENCE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ARTESUNATE; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR3; CHLOROQUINE; EPITOPE; F4 EPITOPE; GAMMA INTERFERON; GRANZYME B; PB1 EPITOPE; PB2 EPITOPE; TETRAMER; UNCLASSIFIED DRUG; T LYMPHOCYTE RECEPTOR;

ANIMAL EXPERIMENT; ANTIGEN SPECIFICITY; ARTICLE; BLOOD BRAIN BARRIER; BRAIN BLOOD VESSEL; BRAIN MALARIA; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CROSS PRESENTATION; DISEASE SEVERITY; EXPERIMENTAL CEREBRAL MALARIA; IN VIVO STUDY; LYMPHOCYTE DIFFERENTIATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MORBIDITY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PARASITE LOAD; PATHOGENESIS; PLASMODIUM BERGHEI; PROTEIN FUNCTION; SPLEEN CELL; AMINO ACID SEQUENCE; ANIMAL; C57BL MOUSE; COMPLICATION; GENE EXPRESSION REGULATION; IMMUNOLOGY; MALARIA; PARASITOLOGY; PHYSIOLOGY;

AMINO ACID SEQUENCE; ANIMALS; BLOOD-BRAIN BARRIER; CD8-POSITIVE T-LYMPHOCYTES; EPITOPES; GENE EXPRESSION REGULATION; MALARIA, CEREBRAL; MICE; MICE, INBRED C57BL; PLASMODIUM BERGHEI; T-CELL ANTIGEN RECEPTOR SPECIFICITY;

EID: 84907959192     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.02180-14     Document Type: Article

References (45)

1. World Health Organization. 2013. World Malaria Report 2012. World Health Organization, Geneva, Switzerland.
2. Dondorp AM, Fanello CI, Hendriksen ICE, Gomes E, Seni A, Chhaganlal KD, Bojang K, Olaosebikan R, Anunobi N, Maitland K, Kivaya E, Agbenyega T, Nguah SB, Evans J, Gesase S, Kahabuka C, Mtove G, Nadjm B, Deen J, Mwanga-Amumpaire J, Nansumba M, Karema C, Umulisa N, Uwimana A, Mokuolu OA, Adedoyin OT, Johnson WBR, Tshefu AK, Onyamboko MA, Sakulthaew T, Ngum WP, Silamut K, Stepniewska K, Woodrow CJ, Bethell D, Wills B, Oneko M, Peto TE, von Seidlein L, Day NPJ, White NJ, AQUAMAT group. 2010. Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial. Lancet 376:1647-1657. http://dx.doi.org/10.1016/S0140-6736(10)61924-1.
3. Engwerda C, Belnoue E, Grüner AC, Renia L. 2005. Experimental models of cerebral malaria. Curr. Top. Microbiol. Immunol. 297:103-143.
4. de Souza JB, Hafalla JCR, Riley EM, Couper KN. 2010. Cerebral malaria: why experimental murine models are required to understand the pathogenesis of disease. Parasitology 137:755-772. http://dx.doi.org/10.1017/S0031182009991715.
5. Rénia L, Gruner AC, Snounou G. 2010. Cerebral malaria: in praise of epistemes. Trends Parasitol. 26:275-277. http://dx.doi.org/10.1016/j.pt.2010.03.005.
6. Amante FH, Haque A, Stanley AC, Rivera FDL, Randall LM, Wilson YA, Yeo G, Pieper C, Crabb BS, de Koning-Ward TF, Lundie RJ, Good MF, Pinzon-Charry A, Pearson MS, Duke MG, McManus DP, Loukas A, Hill GR, Engwerda CR. 2010. Immune-mediated mechanisms of parasite tissue sequestration during experimental cerebral malaria. J. Immunol. 185:3632-3642. http://dx.doi.org/10.4049/jimmunol.1000944.
7. Claser C, Malleret B, Gun SY, Wong AYW, Chang ZW, Teo P, See PCE, Howland SW, Ginhoux F, Rénia L. 2011. CD8+ T cells and IFN-γ mediate the time-dependent accumulation of infected red blood cells in deep organs during experimental cerebral malaria. PLoS One 6:e18720. http://dx.doi.org/10.1371/journal.pone.0018720.
8. Rénia L, Howland SW, Claser C, Charlotte Gruner A, Suwanarusk R, Teo TH, Russell B, Ng LFP. 2012. Cerebral malaria: mysteries at the blood-brain barrier. Virulence 3:193-201. http://dx.doi.org/10.4161/viru.19013.
9. Yañez DM, Manning DD, Cooley AJ, Weidanz WP, van der Heyde HC. 1996. Participation of lymphocyte subpopulations in the pathogenesis of experimental murine cerebral malaria. J. Immunol. 157:1620-1624.
10. Belnoue E, Kayibanda M, Vigário AM, Deschemin J-C, van Rooijen N, Viguier M, Snounou G, Rénia L. 2002. On the pathogenic role of brain-sequestered alphabeta CD8+ T cells in experimental cerebral malaria. J. Immunol. 169:6369-6375. http://dx.doi.org/10.4049/jimmunol.169.11.6369.
11. Amani V, Vigário AM, Belnoue E, Marussig M, Fonseca L, Mazier D, Rénia L. 2000. Involvement of IFN-γ receptor-mediated signaling in pathology and anti-malarial immunity induced by Plasmodium berghei infection. Eur. J. Immunol. 30:1646-1655. http://dx.doi.org/10.1002/1521-4141(200006)30:6<1646::AID-IMMU1646>3.0.CO;2-0.
12. Nitcheu J, Bonduelle O, Combadiere C, Tefit M, Seilhean D, Mazier D, Combadiere B. 2003. Perforin-dependent brain-infiltrating cytotoxic CD8+ T lymphocytes mediate experimental cerebral malaria pathogenesis. J. Immunol. 170:2221-2228. http://dx.doi.org/10.4049/jimmunol.170.4.2221.
13. Haque A, Best SE, Unosson K, Amante FH, de Labastida F, Anstey NM, Karupiah G, Smyth MJ, Heath WR, Engwerda CR. 2011. Granzyme B expression by CD8+ T cells is required for the development of experimental cerebral malaria. J. Immunol. 186:6148-6156. http://dx.doi.org/10.4049/jimmunol.1003955.
14. Rénia L, Potter SM, Mauduit M, Rosa DS, Kayibanda M, Deschemin J-C, Snounou G, Gruner AC. 2006. Pathogenic T cells in cerebral malaria. Int. J. Parasitol. 36:547-554. http://dx.doi.org/10.1016/j.ijpara.2006.02.007.
15. Lou J, Lucas R, Grau GE. 2001. Pathogenesis of cerebral malaria: recent experimental data and possible applications for humans. Clin. Microbiol. Rev. 14:810-820. http://dx.doi.org/10.1128/CMR.14.4.810-820.2001.
16. Kwiatkowski D, Hill AV, Sambou I, Twumasi P, Castracane J, Manogue KR, Cerami A, Brewster DR, Greenwood BM. 1990. TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria. Lancet 336:1201-1204. http://dx.doi.org/10.1016/0140-6736(90)92827-5.
17. Lundie RJ, de Koning-Ward TF, Davey GM, Nie CQ, Hansen DS, Lau LS, Mintern JD, Belz GT, Schofield L, Carbone FR, Villadangos JA, Crabb BS, Heath WR. 2008. Blood-stage Plasmodium infection induces CD8+ T lymphocytes to parasite-expressed antigens, largely regulated by CD8alpha+ dendritic cells. Proc. Natl. Acad. Sci. U. S. A. 105:14509-14514. http://dx.doi.org/10.1073/pnas.0806727105.
18. Miyakoda M, Kimura D, Yuda M, Chinzei Y, Shibata Y, Honma K, Yui K. 2008. Malaria-specific and nonspecific activation of CD8+ T cells during blood stage of Plasmodium berghei infection. J. Immunol. 181:1420-1428. http://dx.doi.org/10.4049/jimmunol.181.2.1420.
19. Howland SW, Poh CM, Gun SY, Claser C, Malleret B, Shastri N, Ginhoux F, Grotenbreg GM, Rénia L. 2013. Brain microvessel crosspresentation is a hallmark of experimental cerebral malaria. EMBO Mol. Med. 5:984-999. http://dx.doi.org/10.1002/emmm.201202273.
20. Lau LS, Fernandez Ruiz D, Davey GM, de Koning-Ward TF, Papenfuss AT, Carbone FR, Brooks AG, Crabb BS, Heath WR. 2011. Blood-stage Plasmodium berghei infection generates a potent, specific CD8+ T-cell response despite residence largely in cells lacking MHC I processing machinery. J. Infect. Dis. 204:1989-1996. http://dx.doi.org/10.1093/infdis/jir656.
21. Yoeli M, Most H. 1965. Studies on sporozoite-induced infections of rodent malaria. I. The pre-erythrocytic tissue stage of Plasmodium berghei. Am. J. Trop. Med. Hyg. 14:700-714.
22. Weiss WR, Good MF, Hollingdale MR, Miller LH, Berzofsky JA. 1989. Genetic control of immunity to Plasmodium yoelii sporozoites. J. Immunol. 143:4263-4266.
23. Malleret B, Claser C, Ong ASM, Suwanarusk R, Sriprawat K, Howland SW, Russell B, Nosten F, Rénia L. 2011. A rapid and robust tri-color flow cytometry assay for monitoring malaria parasite development. Sci. Rep. 1:118. http://dx.doi.org/10.1038/srep00118.
24. Sanderson S, Shastri N. 1994. LacZ inducible, antigen/MHC-specific T cell hybrids. Int. Immunol. 6:369-376. http://dx.doi.org/10.1093/intimm/6.3.369.
25. Grotenbreg GM, Roan NR, Guillen E, Meijers R, Wang J-H, Bell GW, Starnbach MN, Ploegh HL. 2008. Discovery of CD8+ T cell epitopes in Chlamydia trachomatis infection through use of caged class I MHC tetramers. Proc. Natl. Acad. Sci. U. S. A. 105:3831-3836. http://dx.doi.org/10.1073/pnas.0711504105.
26. Schatz PJ. 1993. Use of peptide libraries to map the substrate specificity of a peptide-modifying enzyme: a 13 residue consensus peptide specifies biotinylation in Escherichia coli. Nat. Biotechnol. 11:1138-1143. http://dx.doi.org/10.1038/nbt1093-1138.
27. Rodenko B, Toebes M, Hadrup SR, van Esch WJE, Molenaar AM, Schumacher TNM, Ovaa H. 2006. Generation of peptide-MHC class I complexes through UV-mediated ligand exchange. Nat. Protoc. 1:1120-1132. http://dx.doi.org/10.1038/nprot.2006.121.
28. Chew SL, Or MY, Chang CXL, Gehring AJ, Bertoletti A, Grotenbreg GM. 2011. Stability screening of arrays of major histocompatibility complexes on combinatorially encoded flow cytometry beads. J. Biol. Chem. 286:28466-28475. http://dx.doi.org/10.1074/jbc.M111.262691.
29. Mack M, Cihak J, Simonis C, Luckow B, Proudfoot AE, Plachỳ J, Brühl H, Frink M, Anders HJ, Vielhauer V, Pfirstinger J, Stangassinger M, Schlöndorff D. 2001. Expression and characterization of the chemokine receptors CCR2 and CCR5 in mice. J. Immunol. 166:4697-4704. http://dx.doi.org/10.4049/jimmunol.166.7.4697.
30. Ljunggren HG, Kärre K. 1985. Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism. J. Exp. Med. 162:1745-1759.
31. Rosenberg CS, Martin DL, Tarleton RL. 2010. CD8+ T cells specific for immunodominant trans-sialidase epitopes contribute to control of Trypanosoma cruzi infection but are not required for resistance. J. Immunol. 185:560-568. http://dx.doi.org/10.4049/jimmunol.1000432.
32. Van den Steen PE, Deroost K, Aelst IV, Geurts N, Martens E, Struyf S, Nie CQ, Hansen DS, Matthys P, Damme JV, Opdenakker G. 2008. CXCR3 determines strain susceptibility to murine cerebral malaria by mediating T lymphocyte migration toward IFN-γ-induced chemokines. Eur. J. Immunol. 38:1082-1095. http://dx.doi.org/10.1002/eji.200737906.
33. Campanella GSV, Tager AM, Khoury El JK, Thomas SY, Abrazinski TA, Manice LA, Colvin RA, Luster AD. 2008. Chemokine receptor CXCR3 and its ligands CXCL9 and CXCL10 are required for the development of murine cerebral malaria. Proc. Natl. Acad. Sci. U. S. A. 105:4814-4819. http://dx.doi.org/10.1073/pnas.0801544105.
34. Belnoue E, Kayibanda M, Deschemin J-C, Viguier M, Mack M, Kuziel WA, Rénia L. 2003. CCR5 deficiency decreases susceptibility to experimental cerebral malaria. Blood 101:4253-4259. http://dx.doi.org/10.1182/blood-2002-05-1493.
35. Miu J, Mitchell AJ, Müller M, Carter SL, Manders PM, McQuillan JA, Saunders BM, Ball HJ, Lu B, Campbell IL, Hunt NH. 2008. Chemokine gene expression during fatal murine cerebral malaria and protection due to CXCR3 deficiency. J. Immunol. 180:1217-1230. http://dx.doi.org/10.4049/jimmunol.180.2.1217.
36. Hermsen CC, Mommers E, Van De Wiel T, Sauerwein RW, Eling W. 1998. Convulsions due to increased permeability of the blood-brain barrier in experimental cerebral malaria can be prevented by splenectomy or anti-T cell treatment. J. Infect. Dis. 178:1225-1227. http://dx.doi.org/10.1086/515691.
37. Ponpuak M, Klemba M, Park M, Gluzman IY, Lamppa GK, Goldberg DE. 2007. A role for falcilysin in transit peptide degradation in the Plasmodium falciparum apicoplast. Mol. Microbiol. 63:314-334. http://dx.doi.org/10.1111/j.1365-2958.2006.05443.x.
38. Murata CE, Goldberg DE. 2003. Plasmodium falciparum falcilysin: a metalloprotease with dual specificity. J. Biol. Chem. 278:38022-38028. http://dx.doi.org/10.1074/jbc.M306842200.
39. Eggleson KK, Duffin KL, Goldberg DE. 1999. Identification and characterization of falcilysin, a metallopeptidase involved in hemoglobin catabolism within the malaria parasite Plasmodium falciparum. J. Biol. Chem. 274:32411-32417. http://dx.doi.org/10.1074/jbc.274.45.32411.
40. Tarun AS, Peng X, Dumpit RF, Ogata Y, Silva-Rivera H, Camargo N, Daly TM, Bergman LW, Kappe SHI. 2008. A combined transcriptome and proteome survey of malaria parasite liver stages. Proc. Natl. Acad. Sci. U. S. A. 105:305-310. http://dx.doi.org/10.1073/pnas.0710780104.
41. Mortier A, Van Damme J, Proost P. 2012. Overview of the mechanisms regulating chemokine activity and availability. Immunol. Lett. 145:2-9. http://dx.doi.org/10.1016/j.imlet.2012.04.015.
42. Hanum PS, Hayano M, Kojima S. 2003. Cytokine and chemokine responses in a cerebral malaria-susceptible or -resistant strain of mice to Plasmodium berghei ANKA infection: early chemokine expression in the brain. Int. Immunol. 15:633-640. http://dx.doi.org/10.1093/intimm/dxg065.
43. Meiser A, Mueller A, Wise EL, McDonagh EM, Petit SJ, Saran N, Clark PC, Williams TJ, Pease JE. 2008. The chemokine receptor CXCR3 is degraded following internalization and is replenished at the cell surface by de novo synthesis of receptor. J. Immunol. 180:6713-6724. http://dx.doi.org/10.4049/jimmunol.180.10.6713.
44. Baptista FG, Pamplona A, Pena AC, Mota MM, Pied S, Vigario AM. 2010. Accumulation of Plasmodium berghei-infected red blood cells in the brain is crucial for the development of cerebral malaria in mice. Infect. Immun. 78:4033-4039. http://dx.doi.org/10.1128/IAI.00079-10.
45. Lau LS, Fernandez-Ruiz D, Mollard V, Sturm A, Neller MA, Cozijnsen A, Gregory JL, Davey GM, Jones CM, Lin Y-H, Haque A, Engwerda CR, Nie CQ, Hansen DS, Murphy KM, Papenfuss AT, Miles JJ, Burrows SR, de Koning-Ward T, McFadden GI, Carbone FR, Crabb BS, Heath WR. 2014. CD8+ T cells from a novel T cell receptor transgenic mouse induce liver-stage immunity that can be boosted by blood-stage infection in rodent malaria. PLoS Pathog. 10:e1004135. http://dx.doi.org/10.1371/journal.ppat.1004135.